Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

read more

 

MC Services one of the main sponsors of the 9th DVFA Life Science Conference 2016


MC Services was once again one of the main sponsors of the 9th DVFA Life Science Conference, which took place in Frankfurt on June 14, 2016. Over recent years the DVFA Life Science Conference has become a highly valued platform to discuss new innovative technologies, therapies and products with financial market participants.

This year’s conference titled "Next Level Targeted Therapies – Game Changing Technologies for Future Medicine" focused on innovative treatment strategies and new therapies that have the potential to significantly change the treatment environment. Such a shift in cancer treatment includes immuno-oncology therapies, directing the immune system to eliminate tumor cells, libraries of highly specific and efficient antibodies against a broad portfolio of targets and personalized T-cell immunotherapies that are just some of the key developments in this field. MC Services’ clients have taken leading roles in the development of innovative approaches and exploring new ways of fighting cancer with the potential to transform current treatment approaches.

 

read more

 

MC Services sponsors Best Technology Award at the 2016 European Mediscience Awards


MC Services proudly contributed to this year’s European Mediscience Awards as sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.

 

Mediscience Awards 2016: The winners have been crowned


It is done: after much anticipation the winners of the 2016 Mediscience Awards have been crowned! A huge congratulation to all the winners & shortlisted companies!


read more

 

Please also follow us on Twitter (@MCServicesAG)

Admission of Placing Shares - Total Voting Rights - Directors’ Holdings - Warrant Shares and Block Listing

www.veronapharma.com

RedHill Biopharma Reports 2016 Second Quarter Financial Results

www.redhillbio.com

Nicox raises €18 million to finance development of its pipeline

www.nicox.com

Newron to re-submit US NDA for Xadago® (safinamide) - FDA agrees no additional evaluation of abuse liability or dependence/withdrawal effects in humans is required

www.newron.com

RedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection

www.redhillbio.com

Medigene expands TCR platform technology with US patent for method for identification of CD4+ T cell antigens

www.medigene.com

Result of General Meeting; Appointment of Directors; Total Voting Rights; Application for Block Listing

www.veronapharma.com

InflaRx raises EUR 31 million (US$ 34M) in a Series C financing round to foster complement inhibitor development

www.inflarx.com

Transgene to Continue Phase 1/1b Study with TG1050 in Chronic Hepatitis B Patients on the Recommendation of the Trial’s Safety Review Committee

www.transgene.fr

Newron Pharmaceuticals Announces Initiation of the STARS Study in the United States Potentially Pivotal Study to Evaluate Sarizotan for the Treatment of Apneas in Rett Syndrome

www.newron.com

Adocia presents first half 2016 financial results

www.adocia.fr

Nextech Invest Closes Oncology Fund IV

www.nextechinvest.com

4SC forms international Scientific Expert Panel

www.4sc.com